Contact
Please use this form to send email to PR contact of this press release:
Genfit: GENFIT to Present Additional Data from the Positive Phase 2 Clinical Trial Evaluating Elafibranor in Primary Biliary Cholangitis at the International Liver Congress™ 2019
TO: